ArticleEcancermedicalscience2025
Translation, adaptation and validation of the AWACAN tool for breast and cervical cancer awareness among Arabic-speaking women: a study from Libya.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC) and cervical cancer (CC) pose significant health challenges in the Arab world, exacerbated by limited awareness and restricted access to healthcare services, resulting in poor outcomes and late diagnoses. This study aimed to translate and culturally adapt the African women's awareness cancer (AWACAN) tool for Arabic-speaking women and pilot test it to evaluate its reliability and validity in assessing BC and CC awareness among Arabic-speaking women. Originally developed for Sub-Saharan African populations, the AWACAN tool underwent a systematic translation and adaptation process involving forward and backward translations by bilingual experts. A panel of specialists ensured cultural sensitivity and content validity. The final tool was administered online to a pilot sample of Arabic-speaking women, recruited voluntarily through non-probability sampling on social media. Reliability was evaluated using internal consistency and test-retest reliability, while construct validity was assessed by comparing knowledge scores between medical experts and community participants. The adapted tool comprised of 116 questions covering socio-demographic characteristics, the awareness of BC and CC symptoms, risk factor awareness, help-seeking behaviours, barriers to care and interest in receiving information. The adapted AWACAN tool demonstrated good internal consistency in the 'Known Risk Factors' and 'Symptoms' domains for both BC and CC Kuder-Richardson Formula 20 ranging from 0.682 to 0.871 and strong test-retest reliability (Cohen's kappa values indicating moderate to almost perfect agreement). Construct validity was supported by significantly higher knowledge scores among medical experts. However, the 'Risk Lay Beliefs' domains exhibited moderate to lower reliability. In conclusion, the adapted Arabic version of the AWACAN tool is a reliable and valid instrument for measuring BC and CC awareness among Arabic-speaking women. It can help identify knowledge gaps and inform targeted interventions to improve cancer awareness and early detection efforts in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.